KALA BIO CEO & CFO David Lazar resigns; director Avi Minkowitz appointed same day

KALA BIO, Inc.

David Lazar resigned as CEO and CFO effective Feb 2, 2026, remains on board.
Board appointed director Avi Minkowitz as new CEO and CFO effective same date.
Minkowitz previously VP at Parkit Enterprise and analyst at Leonite Capital.

item 5.02

KALA BIO, Inc. filing history →

Source: SEC EDGAR

accession 0001829126-26-000995

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.